Compare ABT & JPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABT | JPM |
|---|---|---|
| Founded | 1888 | 1799 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.1B | 910.4B |
| IPO Year | 2007 | 2025 |
| Metric | ABT | JPM |
|---|---|---|
| Price | $103.33 | $311.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 28 | 26 |
| Target Price | $119.60 | ★ $373.48 |
| AVG Volume (30 Days) | ★ 6.4M | 5.6M |
| Earning Date | 10-21-2026 | 10-13-2026 |
| Dividend Yield | ★ 2.43% | 2.06% |
| EPS Growth | N/A | ★ 1.37 |
| EPS | 1.67 | ★ 19.20 |
| Revenue | $44,328,000,000.00 | ★ $182,447,000,000.00 |
| Revenue This Year | $12.67 | $13.87 |
| Revenue Next Year | $7.11 | $4.58 |
| P/E Ratio | $62.26 | ★ $16.68 |
| Revenue Growth | ★ 5.67 | 2.75 |
| 52 Week Low | $81.97 | $279.10 |
| 52 Week High | $129.85 | $366.50 |
| Indicator | ABT | JPM |
|---|---|---|
| Relative Strength Index (RSI) | 42.18 | 29.97 |
| Support Level | $100.60 | $304.26 |
| Resistance Level | $104.91 | $315.49 |
| Average True Range (ATR) | 2.72 | 8.54 |
| MACD | -0.91 | -2.95 |
| Stochastic Oscillator | 1.78 | 3.75 |
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
JPMorgan Chase is a leading global financial-services firm with operations in 66 countries and nearly 323,000 employees as of September 2026. Under the JPMorgan brands, the bank holding company boasts a $5.1 trillion balance sheet and $2.78 trillion in deposits as of September 2026. The firm generates its revenue across three core operating segments: consumer and community banking, the commercial and investment bank, and asset and wealth management. It maintains the top global ranking in investment banking fees with an 8.4% market share, serves millions of consumers through its network of over 5,000 US branches, and manages nearly $7.9 trillion in client assets within its wealth and asset management franchise.